Faeth Therapeutics is a startup based in the United States, most recent round Acquired, 2 tracked investors.
Based in the United States, Faeth Therapeutics is a startup founded in 2020. Faeth Therapeutics has been acquired. Brouky records 2 investors associated with the company.
Faeth Therapeutics is a clinical-stage biotechnology company focused on developing cancer treatments through metabolic optimization. The company combines precision nutrition with combination therapies to address cancer metabolism, using a three-pronged approach that includes dual inhibitors, dietary modifications, and chemotherapy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.